Reata Pharmaceuticals, Inc.

RETA · NASDAQ
Analyze with AI
Filings2
Total reported value$6.4M
ManagerSharesValue
Change
Tekla Capital Management LLC34.3K$5.9M+32.4%
PICTET ASSET MANAGEMENT SA2.6K$456.1K-26.7%